Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04362137
Brief Title: Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) (RUXCOVID)

First Submitted : April 22, 2020
First Submitted that Met QC Criteria : April 22, 2020
First Posted : April 24, 2020

Last Update Submitted that Met QC Criteria : November 10, 2020
Last Update Posted : November 12, 2020